Click on a filter below to refine your search. Remove a filter to broaden your search.
Lixisenatide results in less progression of motor disability than placebo at 12 months for individuals with early Parkinson’s disease.
The population-attributable risk estimates suggest that sodium above the recommended intake is linked to 10 to 30% of CVD mortality.
No increase was seen in the incidence of hypotension episodes with replacement of salt by a potassium-enriched substitute.
A high false-positive rate was seen when used in primary care with a diverse patient population.
Tau positron emission tomography predicts all-cause dementia and Alzheimer disease dementia
A reduction was seen in systolic and diastolic blood pressure with self-monitoring plus self-titration of antihypertensive medications.
Hospital eye service follow-up clinics maintain better diagnostic accuracy for active lesions.
The GA enlargement rate in the study eyes did not differ significantly in the run-in and treatment phases in age-related macular degeneration.
Baseline CRP, Clinical Disease Activity Index and glucocorticoid dose predict resistance to CDAI-low disease activity achievement.
No reduction was seen in the number of self-reported exacerbations treated with oral corticosteroids, antibiotics or both.